Free Trial

ArriVent BioPharma (AVBP) Earnings Date, Estimates & Call Transcripts

ArriVent BioPharma logo
$21.30 +0.22 (+1.04%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$21.30 0.00 (0.00%)
As of 05/2/2025 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ArriVent BioPharma Earnings Summary

Upcoming
Earnings Date
May. 14Before Market OpensEstimated
Consensus EPS
(Mar. 3)
-$0.78
Actual EPS
(Mar. 3)
-$0.60 Beat By $0.18

ArriVent BioPharma released Q4 2024 earnings on March 3, 2025, reporting an EPS of -$0.60, which beat analysts' consensus estimates of -$0.78 by $0.18. With a trailing EPS of -$2.57, ArriVent BioPharma's earnings are expected to decrease next year, from ($2.74) to ($3.22) per share.

Q4 2024 Earnings Resources

AVBP Upcoming Earnings

ArriVent BioPharma's Q1 2025 earnings is scheduled for Wednesday, May 14, 2025, with a conference call scheduled on Thursday, May 15, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ArriVent BioPharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ArriVent BioPharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AVBP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ArriVent BioPharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.78-$0.70-$0.74
Q2 20252-$0.84-$0.76-$0.80
Q3 20252-$0.88-$0.86-$0.87
Q4 20252-$0.97-$0.91-$0.94

ArriVent BioPharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2025
(Estimated)
--------
3/3/2025Q4 2024-$0.78-$0.60+$0.18-$0.61--
8/14/2024--$0.65-$0.65--$0.65--
5/8/2024Q1 2024-$0.84-$0.70+$0.14-$0.70--

ArriVent BioPharma Earnings - Frequently Asked Questions

ArriVent BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 14th, 2025 based off last year's report dates. Learn more on AVBP's earnings history.

In the previous quarter, ArriVent BioPharma (NASDAQ:AVBP) reported ($0.60) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.78) by $0.18. Learn more on analysts' earnings estimate vs. AVBP's actual earnings.

ArriVent BioPharma (NASDAQ:AVBP) has a recorded net income of -$69.33 million. AVBP has generated -$2.57 earnings per share over the last four quarters.

ArriVent BioPharma's earnings are expected to decrease from ($2.74) per share to ($3.22) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:AVBP) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners